Index of reports
> Cases with Hypertensive Crisis (19)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Torsemide where reactions include hypertensive crisis. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Torsemide side effects in 45 year old male
Reported by a physician on 2012-05-30
Patient: 45 year old male
Reactions: Vomiting, Nausea, Hyperkalaemia, Hyperglycaemia, Hypotension, Blood Fibrinogen Increased, Treatment Noncompliance, Hypertensive Crisis, Carotid Artery Stenosis, Renal Failure, Glycosylated Haemoglobin Increased, Fluid Intake Reduced, Vertigo, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aleglitazar (Aleglitazar)
Dosage: last dose prior to hyperkalaemia: 04jul2011, dose blinded, temporarily interrupted, frequency qd, or
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-02-15
End date: 2011-07-15
Aleglitazar (Aleglitazar)
Dosage: last dose prior to hyperkalaemia: 04jul2011, dose blinded, temporarily interrupted, frequency qd, or
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-02-15
Torsemide
Dosage: 10;40 g (10;20 mg, 1 in 1;2 in 1 d)
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-23
Torsemide
Dosage: 10;40 g (10;20 mg, 1 in 1;2 in 1 d)
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-08
End date: 2011-05-09
Spironolactone
Dosage: 125 mg (125 mg, 1 in 1 d)
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-04
End date: 2011-05-06
Other drugs received by patient: Clopidogrel Bisulfate; Catapressan (Clonidine Hydrochloride); Inegy (Ezetimibe, Simvasatin); Aliskiren (Aliskiren Fumarate); Hydrochlorothiazide; Nitrolingual (Nitroglycerin); Diovan; Tramabeta (Tramadol Hydrochloride); Aspirin; Nebivolol HCL; Allopurinol; Vilodagliptin (Vildagliptin); Amlodipine; Metfformin Hydrochloride; Liprogol (Lispro Insulin); Pantoprazole; Levemir; Omega-3 Acid Ethyl Esgters (Omega-3 Acid Ethyl Esters); Targin (Naloxone Hydrochloride, Oxycodone Hydrochloride)
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-05-23
Patient: male
Reactions: Carotid Artery Stenosis, Hyperkalaemia, Hypertensive Crisis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Aleglitazar and Blinded Aleglitazar
Dosage: last dose prior to hyperkalaemia: 04/jul/2011, hypertensive crisis: 11/aug/2011
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Spironolactone
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-04
End date: 2011-05-06
Spironolactone
Torsemide
Torsemide
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-08
End date: 2011-05-09
Other drugs received by patient: Tramabeta; Nebivolol HCL; Ezetimibe; Vildagliptin; Liprolog; Omega-3-Acid Ethyl Esters; Aliskiren; Nitrolingual; Opium / Naloxone TAB; Clopidogrel; Amlodipine; Levemir; Allopurinol; Pantoprazole; Amlodipine; Nitrolingual; Metformin HCL; Aspirin; Amlodipine; Hydrochlorothiazide; Catapres; Diovan; Diovan
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-05-14
Patient: male, weighing 130.0 kg (286.0 pounds)
Reactions: Dyspnoea, Refractory Anaemia, Diabetic Foot, Gout, Angina Pectoris, Impaired Work Ability, Left Ventricular Hypertrophy, Myelodysplastic Syndrome, Albumin Urine Present, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Torsemide
Dosage: 20 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-14
Diovan
Dosage: 160 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
End date: 2009-03-19
Lercanidipine
Dosage: 40 mg/d
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Diovan HCT
Dosage: 160/12.5 mg per day
Administration route: Oral
Indication: Hypertension
Diovan
Dosage: 320 mg,daily
Administration route: Oral
Start date: 2009-03-19
End date: 2011-01-10
Rasilez
Dosage: 300 mg daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-11-14
End date: 2012-02-15
Valsartan
Dosage: 320 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Doxazosin Mesylate
Dosage: 8 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-27
Other drugs received by patient: Diuretics; Insulin Human; Adenuric; Nebivolol HCL; Simvastatin; Aspirin; Humalog; Pantoprazole; Metformin HCL; Other Antihypertensives; Simvastatin
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-05-14
Patient: male, weighing 130.0 kg (286.0 pounds)
Reactions: Dyspnoea, Refractory Anaemia, Gout, Diabetic Foot, Angina Pectoris, Impaired Work Ability, Myelodysplastic Syndrome, Left Ventricular Hypertrophy, Albumin Urine Present, Hypertensive Crisis, Creatinine Urine Increased, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Blood Pressure Diastolic Decreased
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Diovan HCT
Dosage: 160/12.5 mg per day
Administration route: Oral
Indication: Hypertension
Diovan
Dosage: 160 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
End date: 2009-03-19
Valsartan
Dosage: 320 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Doxazosin Mesylate
Dosage: 8 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-27
Rasilez
Dosage: 300 mg daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-11-14
End date: 2012-02-15
Torsemide
Dosage: 20 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-14
Lercanidipine
Dosage: 40 mg/d
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Diovan
Dosage: 320 mg,daily
Administration route: Oral
Start date: 2009-03-19
End date: 2011-01-10
Other drugs received by patient: Aspirin; Pantoprazole; Other Antihypertensives; Simvastatin; Nebivolol HCL; Humalog; Simvastatin; Metformin HCL; Insulin Human; Adenuric; Diuretics
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-05-04
Patient: male, weighing 130.0 kg (286.0 pounds)
Reactions: Refractory Anaemia, Dyspnoea, Diabetic Foot, Gout, Angina Pectoris, Impaired Work Ability, Myelodysplastic Syndrome, Left Ventricular Hypertrophy, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Diovan HCT
Dosage: 1 df, unk
Administration route: Oral
Indication: Hypertension
Diovan
Dosage: 160 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
End date: 2009-03-19
Rasilez
Dosage: 300 mg daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-11-14
End date: 2012-02-15
Valsartan
Dosage: 320 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Torsemide
Dosage: 20 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-14
Doxazosin Mesylate
Dosage: 8 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-27
Lercanidipine
Dosage: 40 mg/d
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Diovan
Dosage: 320 mg,daily
Administration route: Oral
Start date: 2009-03-19
End date: 2011-01-10
Other drugs received by patient: Humalog; Adenuric; Metformin HCL; Simvastatin; Insulin Human; Simvastatin; Pantoprazole; Diuretics; Aspirin; Nebivolol HCL; Other Antihypertensives
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-05-04
Patient: male, weighing 130.0 kg (286.0 pounds)
Reactions: Dyspnoea, Refractory Anaemia, Angina Pectoris, Gout, Diabetic Foot, Impaired Work Ability, Left Ventricular Hypertrophy, Myelodysplastic Syndrome, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Rasilez
Dosage: 300 mg daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-11-14
End date: 2012-02-15
Diovan
Dosage: 160 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
End date: 2009-03-19
Torsemide
Dosage: 20 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-14
Diovan HCT
Dosage: 1 df, unk
Administration route: Oral
Indication: Hypertension
Valsartan
Dosage: 320 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Doxazosin Mesylate
Dosage: 8 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-27
Diovan
Dosage: 320 mg,daily
Administration route: Oral
Start date: 2009-03-19
End date: 2011-01-10
Carmen
Dosage: 40 mg/d
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Other drugs received by patient: Diuretics; Other Antihypertensives; Nebivolol HCL; Aspirin; Simvastatin; Pantoprazole; Metformin HCL; Insulin Human; Adenuric; Humalog; Simvastatin
Possible Torsemide side effects in 45 year old male
Reported by a physician on 2012-04-13
Patient: 45 year old male
Reactions: Blood Creatine Phosphokinase Increased, Vomiting, Hyperkalaemia, Nausea, Hyperglycaemia, Blood Fibrinogen Increased, Hypertensive Crisis, Carotid Artery Stenosis, Gamma-Glutamyltransferase Increased, Vertigo, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Spironolactone
Dosage: 1 dosage forms (1 dosage forms, 1 in 1 d)
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-04
Aleglitazar (Aleglitazar)
Dosage: last dose prior to hyperkalaemia:04jul2011, dose blinded, temporarily interrupted, frequency qd, ora
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-02-15
Aleglitazar (Aleglitazar)
Dosage: last dose prior to hyperkalaemia:04jul2011, dose blinded, temporarily interrupted, frequency qd, ora
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2010-01-08
End date: 2011-05-09
Aleglitazar (Aleglitazar)
Dosage: last dose prior to hyperkalaemia:04jul2011, dose blinded, temporarily interrupted, frequency qd, ora
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-08-11
Torsemide
Dosage: 10 mg (10 mg, 1 in 1 d)
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-08
End date: 2011-05-09
Other drugs received by patient: Pantoprazole; Metformin HCL; Aliskiren (Aliskiren Fumarate); Catapressan (Clonidine Hydrochloride); Amlodipine; Allopurinol; Levemir; Vildagliptin (Vildagliptin); Nitrolingual (Nitroglycerin); Clopidogrel Bisulfate; Nebivolol HCL; Hydrochlorothiazide; Inegy (Ezetimibe, Simvastatin); Liprolog (Lispro Insulin); Omega-3 Acid Ethyl Esters (Omega-3 Acid Ethyl Esters); Diovan; Aspirin
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-04-05
Patient: male
Reactions: Carotid Artery Stenosis, Hyperkalaemia, Treatment Noncompliance, Hypertensive Crisis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Aleglitazar
Dosage: last dose prior to hyperkalaemia: 04/jul/2011, hypertensive crisis: 11/aug/2011
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Torsemide
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-08
End date: 2011-05-09
Spironolactone
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Amlodipine; Liprolog; Catapres; Amlodipine; Ezetimibe; Metformin HCL; Omega-3-Acid Ethyl Esters; Nitrolingual; Clopidogrel; Allopurinol; Pantoprazole; Levemir; Aspirin; Nebivolol HCL; Vildagliptin; Nitrolingual; Diovan; Hydrochlorothiazide; Diovan; Aliskiren
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-03-22
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Intracardiac Thrombus, Left Ventricular Failure, Hypertensive Crisis, Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Torsemide
Dosage: 7.5 mg, daily
Administration route: Oral
Indication: Cardiac Failure
Start date: 2008-01-01
Procoralan
Dosage: 10 mg, daily
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-01-01
Rasilez
Administration route: Oral
Indication: Hypertension
Falithrom
Dosage: 3 mg, daily
Administration route: Oral
Indication: Thrombophlebitis Superficial
Start date: 2009-01-01
Diovan HCT
Dosage: 80 /25 mg, daily
Indication: Cardiac Failure
Start date: 2008-01-01
Fluvastatin Sodium
Dosage: 30 mg, daily
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2008-01-01
Glimepiride
Dosage: 4 mg , daily
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2008-01-01
Bisoprolol Fumarate
Dosage: 7.5 mg, daily
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2008-01-01
Rasilez
Dosage: 150 mg, daily
End date: 2012-01-17
Diovan HCT
Dosage: 160 /25 mg, daily
Diovan HCT
Dosage: 320/25 mg, daily
Metformin HCL
Dosage: 2000 mg, daily
Start date: 2008-01-01
Other drugs received by patient: Platelet Aggregation Inhibitors; Thienopyridine; Anticoagulants
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-03-22
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Left Ventricular Failure, Intracardiac Thrombus, Hypertensive Crisis, Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Diovan HCT
Dosage: 80 /25 mg, daily
Indication: Cardiac Failure
Start date: 2008-01-01
Procoralan
Dosage: 10 mg, daily
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-01-01
Falithrom
Dosage: 3 mg, daily
Administration route: Oral
Indication: Thrombophlebitis Superficial
Start date: 2009-01-01
Rasilez
Administration route: Oral
Indication: Hypertension
Fluvastatin Sodium
Dosage: 30 mg, daily
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2008-01-01
Torsemide
Dosage: 7.5 mg, daily
Administration route: Oral
Indication: Cardiac Failure
Start date: 2008-01-01
Glimepiride
Dosage: 4 mg , daily
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2008-01-01
Metformin HCL
Dosage: 2000 mg, daily
Start date: 2008-01-01
Diovan HCT
Dosage: 320/25 mg, daily
Bisoprolol Fumarate
Dosage: 7.5 mg, daily
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2008-01-01
Rasilez
Dosage: 150 mg, daily
End date: 2012-01-17
Diovan HCT
Dosage: 160 /25 mg, daily
Other drugs received by patient: Platelet Aggregation Inhibitors; Thienopyridine; Anticoagulants
Possible Torsemide side effects in male
Reported by a individual with unspecified qualification from Germany on 2012-03-15
Patient: male
Reactions: Carotid Artery Stenosis, Hyperkalaemia, Hypertensive Crisis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Aleglitazar
Dosage: last dose prior to hyperkalaemia: 04/jul/2011, hypertensive crisis: 11/aug/2011
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Torsemide
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-08
End date: 2011-05-09
Spironolactone
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Aspirin; Amlodipine; Liprolog; Hydrochlorothiazide; Aliskiren; Nitrolingual; Metformin HCL; Omega-3-Acid Ethyl Esters; Clopidogrel; Levemir; Vildagliptin; Nebivolol HCL; Nitrolingual; Diovan; Diovan; Ezetimibe; Amlodipine; Allopurinol; Catapres; Pantoprazole
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-03-14
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Coronary Artery Thrombosis, Left Ventricular Failure, Hypertensive Crisis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Rasilez
Administration route: Oral
Indication: Hypertension
Metformin HCL
Dosage: 2000 mg, daily
Start date: 2008-01-01
Rasilez
Dosage: 150 mg, daily
End date: 2012-01-17
Diovan HCT
Dosage: 320/25 mg, daily
Falithrom
Dosage: 3 mg, daily
Administration route: Oral
Indication: Thrombophlebitis Superficial
Start date: 2009-01-01
Fluvastatin Sodium
Dosage: 30 mg, daily
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2008-01-01
Torsemide
Dosage: 7.5 mg, daily
Administration route: Oral
Indication: Cardiac Failure
Start date: 2008-01-01
Diovan HCT
Dosage: 160 /25 mg, daily
Procoralan
Dosage: 10 mg, daily
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-01-01
Diovan HCT
Dosage: 80 /25 mg, daily
Indication: Cardiac Failure
Start date: 2008-01-01
Glimepiride
Dosage: 4 mg , daily
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2008-01-01
Bisoprolol Fumarate
Dosage: 7.5 mg, daily
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2008-01-01
Other drugs received by patient: Thienopyridine; Platelet Aggregation Inhibitors; Anticoagulants
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-03-14
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Coronary Artery Thrombosis, Left Ventricular Failure, Hypertensive Crisis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Rasilez
Administration route: Oral
Indication: Hypertension
Fluvastatin Sodium
Dosage: 30 mg, daily
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2008-01-01
Procoralan
Dosage: 10 mg, daily
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-01-01
Falithrom
Dosage: 3 mg, daily
Administration route: Oral
Indication: Thrombophlebitis Superficial
Start date: 2009-01-01
Diovan HCT
Dosage: 80 /25 mg, daily
Indication: Cardiac Failure
Start date: 2008-01-01
Diovan HCT
Dosage: 160 /25 mg, daily
Bisoprolol Fumarate
Dosage: 7.5 mg, daily
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2008-01-01
Rasilez
Dosage: 150 mg, daily
End date: 2012-01-17
Diovan HCT
Dosage: 320/25 mg, daily
Metformin HCL
Dosage: 2000 mg, daily
Start date: 2008-01-01
Torsemide
Dosage: 7.5 mg, daily
Administration route: Oral
Indication: Cardiac Failure
Start date: 2008-01-01
Glimepiride
Dosage: 4 mg , daily
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2008-01-01
Other drugs received by patient: Platelet Aggregation Inhibitors; Thienopyridine; Anticoagulants
Possible Torsemide side effects in 45 year old male
Reported by a physician on 2012-01-31
Patient: 45 year old male
Reactions: Vomiting, Nausea, Hyperkalaemia, Hypotension, Hyperglycaemia, Headache, Treatment Noncompliance, Hyperhidrosis, Hypertensive Crisis, Carotid Artery Stenosis, Glycosylated Haemoglobin Increased, Vertigo, Dizziness, Fluid Intake Reduced, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aleglitazar (Aleglitazer)
Dosage: see image
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-02-15
Aleglitazar (Aleglitazer)
Dosage: see image
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-02-15
Spironolactone
Dosage: 1 dosage forms (1 dosage forms, 1 in 1 d)
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-04
Torsemide
Dosage: 10 mg (10 mg,l in 1 d)
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-08
End date: 2011-05-09
Other drugs received by patient: Inegy(ezetimibe, Simvastatin); Diovan; Aspirin; Omega-3 Acid Ethyl Esters(omega-3 Acid Ethyl Esters); Amlodipine; Liprolog (Lispro Insulin); Aliskiren (Aliskiren Fumarate); Allopurinol; Hydrocrlorothiazide (Hydrochlorothiazide); Catapressan (Clonidine Hydrochloride); Colopidogrel Bisulfate(clopidogrel Bisulfate); Pantoprazole; Metformin HCL; Nitrolingual (Nitroglycerin); Levemir; Vildagliptin (Vildagliptin); Nebilet(nebivoloi Hydrochloride)
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-01-30
Patient: male
Reactions: Carotid Artery Stenosis, Hyperkalaemia, Hypertensive Crisis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Torsemide
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-08
End date: 2011-05-09
Blinded Aleglitazar
Dosage: last dose prior to hyperkalaemia: 04/jul/2011, hypertensive crisis: 11/aug/2011
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Spironolactone
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Amlodipine; Ezetimibe; Diovan; Amlodipine; Vildagliptin; Hydrochlorothiazide; Nitrolingual; Pantoprazole; Levemir; Aspirin; Clopidogrel; Metfformin Hydrochloride; Aliskiren; Catapres; Liprolog; Nebivolol HCL; Allopurinol; Diovan; Omega-3-Acid Ethyl Esters; Nitrolingual
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-01-26
Patient: male
Reactions: Carotid Artery Stenosis, Hyperkalaemia, Hypertensive Crisis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Torsemide
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-08
End date: 2011-05-09
Blinded Aleglitazar
Dosage: last dose prior to hyperkalaemia: 04/jul/2011, hypertensive crisis: 11/aug/2011
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Spironolactone
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Clopidogrel; Ezetimibe; Pantoprazole; Aliskiren; Nitrolingual; Amlodipine; Aspirin; Omega-3-Acid Ethyl Esters; Hydrochlorothiazide; Nebivolol HCL; Liprolog; Amlodipine; Diovan; Levemir; Vildagliptin; Catapres; Allopurinol; Metformin HCL; Nitrolingual; Diovan
Possible Torsemide side effects in 45 year old male
Reported by a physician on 2012-01-23
Patient: 45 year old male
Reactions: Vomiting, Nausea, Hyperkalaemia, Treatment Noncompliance, Hypertensive Crisis, Carotid Artery Stenosis, Renal Impairment, Glycosylated Haemoglobin Increased, Blood Glucose Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Spironolactone
Dosage: 1 dosage forms (1 dosage forms, 1 in 1 d)
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-04
Torsemide
Dosage: 10 mg (10 mg, 1 in 1 d)
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-08
End date: 2011-05-09
Aleglitazar (Aleglitazar)
Dosage: last dose prior to hyperkalaemia: 04jul2011, dose blinded, temporarily interuppted, frequency qd, o
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-02-15
Aleglitazar (Aleglitazar)
Dosage: last dose prior to hyperkalaemia: 04jul2011, dose blinded, temporarily interuppted, frequency qd, o
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-02-15
Other drugs received by patient: Allopurinol; Omega-3 Acid Ethyl Esters (Omega-3 Acid Ethyl Esters); Aliskiren (Aliskiren Fumarate); Catapressan (Clonidine Hydrochloride); Liprolog (Lispro Insulin); Aspirin; Levemir; Clopidogrel Bisulfate; Pantoprazole; Vildagliptin (Vildagliptin); Nitrolingual (Nitroglycerin); Nebivolol HCL; Inegy (Ezetimibe, Simvastatin); Amlodipine; Metformin HCL; Hydrochlorothiazide; Diovan
Possible Torsemide side effects in 45 year old male
Reported by a physician on 2012-01-05
Patient: 45 year old male
Reactions: Vomiting, Aortic Stenosis, Hyperkalaemia, Nausea, Hyperglycaemia, Hypertensive Crisis, Carotid Artery Stenosis, Renal Impairment, Blood Pressure Fluctuation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Torsemide
Dosage: 10 mg (10 mg, 1 in 1 d)
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-08
End date: 2011-05-09
Spironolactone
Dosage: 1 dosage forms (1 dosage forms, 1 in1 d)
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-04
Aleglitazar (Aleglitazar)
Dosage: oral (lst dose prior to hyperkalaemia
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-02-15
Aleglitazar (Aleglitazar)
Dosage: oral (lst dose prior to hyperkalaemia
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-02-15
Other drugs received by patient: Liprolog (Lispro Insulin); Omega-3 Acid Ethyl Esters (Omega-3 Acid Ethyl Esters); Diovan; Aspirin; Inegy (Ezetimibe, Simvastatin); Clopidogrel Bisulfate; Allopurinol; Metformin HCL; Nebivolol HCL; Vildagliptin (Vildagliptin); Catapressan (Clonidine Hydrochloride); Nitrolingual (Nitroglycerin); Amlodipine; Pantoprazole; Levemir; Aliskiren (Aliskiren Fumarate); Hydrochlorothiazide
Possible Torsemide side effects in 45 year old male
Reported by a physician on 2011-10-12
Patient: 45 year old male
Reactions: Carotid Artery Stenosis, Renal Impairment, Vomiting, Hyperkalaemia, Hypertensive Crisis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aleglitazar (Aleglitazar)
Dosage: see image
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-02-15
Aleglitazar (Aleglitazar)
Dosage: see image
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2011-02-15
Spironolactone
Dosage: 1 dosage forms (1 dosage forms,1 in 1 d)
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-04
Torsemide
Dosage: 10 mg (10 mg,1 in 1 d)
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-08
Other drugs received by patient: Inegy (Ezetimibe, Simvastatin); Vildagliptin (Vildagliptin); Pantoprazole; Aliskiren (Aliskiren Fumarate); Catapressan (Clonidine Hydrochloride); Omega-3 Acid Ethyl Esters (Omega-3 Acid Ethyl Esters); Clopidogrel Bisulfate; Amlodipine; Levemir; Nitrolingual (Nitroglycerin); Metformin HCL; Liprolog (Lispro Insulin); Nebivolol HCL; Allopurinol; Aspirin; Hydrochlorothiazide; Diovan
|